Do analysts recommend RVP or RBOT?

Vicarious Surgical has a consensus price target of $7.00, suggesting a potential upside of 1,473.03%. Given Vicarious Surgical's stronger consensus rating and higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Vicarious Surgical 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67

Is HIND or RBOT more profitable?

Vicarious Surgical has a net margin of 0.00% compared to Vyome's net margin of -270.58%. Vicarious Surgical's return on equity of -184.13% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Vyome -270.58% -203.92% -134.16% Vicarious Surgical N/A -184.13% -112.50%

Does the media prefer HIND or RBOT?

In the previous week, Vyome had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for Vyome and 1 mentions for Vicarious Surgical. Vyome's average media sentiment score of 0.72 beat Vicarious Surgical's score of 0.00 indicating that Vyome is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vyome 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vicarious Surgical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend RBOT or OSRH?

Vicarious Surgical presently has a consensus price target of $7.00, indicating a potential upside of 1,473.03%. Given Vicarious Surgical's stronger consensus rating and higher probable upside, equities analysts plainly believe Vicarious Surgical is more favorable than OSR. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is RBOT or OSRH more profitable?

Vicarious Surgical has a net margin of 0.00% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Vicarious Surgical's return on equity. Company Net Margins Return on Equity Return on Assets Vicarious Surgical N/A -184.13% -112.50% OSR -363.26% -7.24% -5.41%

Does the media prefer RBOT or OSRH?

In the previous week, OSR had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for OSR and 1 mentions for Vicarious Surgical. OSR's average media sentiment score of 0.47 beat Vicarious Surgical's score of 0.00 indicating that OSR is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vicarious Surgical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OSR 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RBOT or ICU?

In the previous week, SeaStar Medical had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for SeaStar Medical and 1 mentions for Vicarious Surgical. SeaStar Medical's average media sentiment score of 0.93 beat Vicarious Surgical's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vicarious Surgical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SeaStar Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is RBOT or SURG more profitable?

Vicarious Surgical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. Vicarious Surgical's return on equity of -184.13% beat SurgePays' return on equity. Company Net Margins Return on Equity Return on Assets Vicarious Surgical N/A -184.13% -112.50% SurgePays -64.91% -967.32% -310.16%

Does the media refer more to RBOT or SURG?

In the previous week, SurgePays had 7 more articles in the media than Vicarious Surgical. MarketBeat recorded 8 mentions for SurgePays and 1 mentions for Vicarious Surgical. SurgePays' average media sentiment score of 0.97 beat Vicarious Surgical's score of 0.00 indicating that SurgePays is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vicarious Surgical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SurgePays 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Vicarious Surgical (RBOT) Competitors

$0.44 -0.08 (-14.42%)

As of 03:59 PM Eastern

Compare

RBOT vs. RVP, HIND, OSRH, ICU, and SURG

Should you buy Vicarious Surgical stock or one of its competitors? MarketBeat compares Vicarious Surgical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Vicarious Surgical include Retractable Technologies (RVP), Vyome (HIND), OSR (OSRH), SeaStar Medical (ICU), and SurgePays (SURG). These companies are all part of the "medical equipment" industry.

How does Vicarious Surgical compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

In the previous week, Vicarious Surgical had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 1 mentions for Vicarious Surgical and 0 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 equaled Vicarious Surgical'saverage media sentiment score.

Company	Overall Sentiment
Retractable Technologies	Neutral
Vicarious Surgical	Neutral

Retractable Technologies has higher revenue and earnings than Vicarious Surgical. Retractable Technologies is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A

Vicarious Surgical has a consensus price target of $7.00, suggesting a potential upside of 1,473.03%. Given Vicarious Surgical's stronger consensus rating and higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vicarious Surgical	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 9.5% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Retractable Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, Vicarious Surgical has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market.

Vicarious Surgical has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Vicarious Surgical	N/A	-184.13%	-112.50%

Summary

Vicarious Surgical beats Retractable Technologies on 7 of the 13 factors compared between the two stocks.

How does Vicarious Surgical compare to Vyome?

Vyome (NASDAQ:HIND) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

In the previous week, Vyome had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for Vyome and 1 mentions for Vicarious Surgical. Vyome's average media sentiment score of 0.72 beat Vicarious Surgical's score of 0.00 indicating that Vyome is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vyome	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vicarious Surgical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

22.1% of Vyome shares are held by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are held by institutional investors. 33.0% of Vyome shares are held by company insiders. Comparatively, 9.5% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Vyome has higher revenue and earnings than Vicarious Surgical. Vyome is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$320K	47.60	-$10.26M	-$12.27	N/A
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A

Vyome currently has a consensus target price of $15.00, suggesting a potential upside of 591.24%. Vicarious Surgical has a consensus target price of $7.00, suggesting a potential upside of 1,473.03%. Given Vicarious Surgical's higher probable upside, analysts plainly believe Vicarious Surgical is more favorable than Vyome.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Vicarious Surgical	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Vyome has a beta of 1.48, suggesting that its share price is 48% more volatile than the broader market. Comparatively, Vicarious Surgical has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market.

Vicarious Surgical has a net margin of 0.00% compared to Vyome's net margin of -270.58%. Vicarious Surgical's return on equity of -184.13% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	-270.58%	-203.92%	-134.16%
Vicarious Surgical	N/A	-184.13%	-112.50%

Summary

Vicarious Surgical beats Vyome on 8 of the 15 factors compared between the two stocks.

How does Vicarious Surgical compare to OSR?

Vicarious Surgical (NYSE:RBOT) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

OSR has higher revenue and earnings than Vicarious Surgical. OSR is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
OSR	$2.91M	5.04	-$27.06M	-$0.33	N/A

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 9.5% of Vicarious Surgical shares are held by insiders. Comparatively, 36.8% of OSR shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Vicarious Surgical has a net margin of 0.00% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
OSR	-363.26%	-7.24%	-5.41%

Vicarious Surgical has a beta of 1.76, indicating that its share price is 76% more volatile than the broader market. Comparatively, OSR has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market.

In the previous week, OSR had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for OSR and 1 mentions for Vicarious Surgical. OSR's average media sentiment score of 0.47 beat Vicarious Surgical's score of 0.00 indicating that OSR is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vicarious Surgical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OSR	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Vicarious Surgical presently has a consensus price target of $7.00, indicating a potential upside of 1,473.03%. Given Vicarious Surgical's stronger consensus rating and higher probable upside, equities analysts plainly believe Vicarious Surgical is more favorable than OSR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

OSR beats Vicarious Surgical on 9 of the 14 factors compared between the two stocks.

How does Vicarious Surgical compare to SeaStar Medical?

Vicarious Surgical (NYSE:RBOT) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

Vicarious Surgical currently has a consensus target price of $7.00, suggesting a potential upside of 1,473.03%. SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 204.18%. Given Vicarious Surgical's higher probable upside, research analysts clearly believe Vicarious Surgical is more favorable than SeaStar Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Vicarious Surgical has a net margin of 0.00% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Vicarious Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
SeaStar Medical	-828.62%	-146.29%	-96.48%

SeaStar Medical has higher revenue and earnings than Vicarious Surgical. SeaStar Medical is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
SeaStar Medical	$1.23M	8.55	-$12.15M	-$4.80	N/A

47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 9.5% of Vicarious Surgical shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Vicarious Surgical has a beta of 1.76, meaning that its share price is 76% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, meaning that its share price is 205% less volatile than the broader market.

In the previous week, SeaStar Medical had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for SeaStar Medical and 1 mentions for Vicarious Surgical. SeaStar Medical's average media sentiment score of 0.93 beat Vicarious Surgical's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vicarious Surgical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SeaStar Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

SeaStar Medical beats Vicarious Surgical on 9 of the 15 factors compared between the two stocks.

How does Vicarious Surgical compare to SurgePays?

Vicarious Surgical (NYSE:RBOT) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

In the previous week, SurgePays had 7 more articles in the media than Vicarious Surgical. MarketBeat recorded 8 mentions for SurgePays and 1 mentions for Vicarious Surgical. SurgePays' average media sentiment score of 0.97 beat Vicarious Surgical's score of 0.00 indicating that SurgePays is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vicarious Surgical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SurgePays	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Vicarious Surgical has a net margin of 0.00% compared to SurgePays' net margin of -64.91%. Vicarious Surgical's return on equity of -184.13% beat SurgePays' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
SurgePays	-64.91%	-967.32%	-310.16%

SurgePays has higher revenue and earnings than Vicarious Surgical. SurgePays is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
SurgePays	$56.96M	0.20	-$36.07M	-$1.94	N/A

Vicarious Surgical currently has a consensus target price of $7.00, indicating a potential upside of 1,473.03%. SurgePays has a consensus target price of $3.50, indicating a potential upside of 663.36%. Given Vicarious Surgical's higher possible upside, equities analysts clearly believe Vicarious Surgical is more favorable than SurgePays.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
SurgePays	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Vicarious Surgical has a beta of 1.76, suggesting that its stock price is 76% more volatile than the broader market. Comparatively, SurgePays has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 6.9% of SurgePays shares are owned by institutional investors. 9.5% of Vicarious Surgical shares are owned by insiders. Comparatively, 29.1% of SurgePays shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Vicarious Surgical and SurgePays tied by winning 7 of the 14 factors compared between the two stocks.

Get Vicarious Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RBOT vs. The Competition

Export

Metric	Vicarious Surgical	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$3.17M	$7.42B	$6.50B	$23.11B
Dividend Yield	N/A	1.19%	2.67%	4.08%
P/E Ratio	-0.05	38.62	20.85	27.39
Price / Sales	N/A	73.08	500.87	20.96
Price / Cash	N/A	25.48	43.05	24.21
Price / Book	0.06	6.93	10.43	4.59
Net Income	-$63.22M	$159.22M	$3.56B	$1.07B
7 Day Performance	-33.53%	-1.91%	-1.39%	-0.60%
1 Month Performance	-19.09%	3.26%	0.86%	-1.14%
1 Year Performance	-94.32%	-2.82%	19.42%	18.94%

Vicarious Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RBOT Vicarious Surgical	1.5987 of 5 stars	$0.45 -14.4%	$7.00 +1,473.0%	-93.3%	$3.17M	N/A	N/A	210
RVP Retractable Technologies	N/A	$0.67 -4.0%	N/A	+3.3%	$20.03M	$37.15M	N/A	240
HIND Vyome	3.1611 of 5 stars	$2.30 -0.9%	$15.00 +552.2%	N/A	$16.15M	$320K	N/A	50	Short Interest Decrease Gap Down
OSRH OSR	1.096 of 5 stars	$0.41 -5.2%	N/A	-72.2%	$14.28M	$2.91M	N/A	N/A	News Coverage
ICU SeaStar Medical	3.3406 of 5 stars	$3.53 -3.0%	$8.00 +126.6%	-78.1%	$14.12M	$1.23M	N/A	2

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RBOT) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vicarious Surgical (RBOT) Competitors

RBOT vs. RVP, HIND, OSRH, ICU, and SURG

How does Vicarious Surgical compare to Retractable Technologies?

Summary

How does Vicarious Surgical compare to Vyome?

Summary

How does Vicarious Surgical compare to OSR?

Summary

How does Vicarious Surgical compare to SeaStar Medical?

Summary

How does Vicarious Surgical compare to SurgePays?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT vs. The Competition

Vicarious Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vicarious Surgical (RBOT) Competitors

RBOT vs. RVP, HIND, OSRH, ICU, and SURG

How does Vicarious Surgical compare to Retractable Technologies?

Does the media favor RVP or RBOT?

Which has stronger valuation and earnings, RVP or RBOT?

Do analysts recommend RVP or RBOT?

Do institutionals and insiders hold more shares of RVP or RBOT?

Which has more volatility and risk, RVP or RBOT?

Is RVP or RBOT more profitable?

Summary

How does Vicarious Surgical compare to Vyome?

Does the media prefer HIND or RBOT?

Do insiders & institutionals believe in HIND or RBOT?

Which has higher valuation and earnings, HIND or RBOT?

Do analysts rate HIND or RBOT?

Which has more volatility and risk, HIND or RBOT?

Is HIND or RBOT more profitable?

Summary

How does Vicarious Surgical compare to OSR?

Which has higher earnings and valuation, RBOT or OSRH?

Do insiders & institutionals have more ownership in RBOT or OSRH?

Is RBOT or OSRH more profitable?

Which has more risk and volatility, RBOT or OSRH?

Does the media prefer RBOT or OSRH?

Do analysts recommend RBOT or OSRH?

Summary

How does Vicarious Surgical compare to SeaStar Medical?

Do analysts prefer RBOT or ICU?

Is RBOT or ICU more profitable?

Which has better earnings & valuation, RBOT or ICU?

Do institutionals & insiders hold more shares of RBOT or ICU?

Which has more risk & volatility, RBOT or ICU?

Does the media refer more to RBOT or ICU?

Summary

How does Vicarious Surgical compare to SurgePays?

Does the media refer more to RBOT or SURG?

Is RBOT or SURG more profitable?

Which has better valuation & earnings, RBOT or SURG?

Do analysts prefer RBOT or SURG?

Which has more volatility and risk, RBOT or SURG?

Do institutionals & insiders have more ownership in RBOT or SURG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT vs. The Competition

Vicarious Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools